KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & Amortization
Ratios

Arbutus Biopharma (ABUS) Depreciation Expense (2016 - 2021)

Historic Depreciation Expense for Arbutus Biopharma (ABUS) over the last 13 years, with Q3 2021 value amounting to $447000.0.

  • Arbutus Biopharma's Depreciation Expense fell 877.55% to $447000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $1.8 million, marking a year-over-year decrease of 925.93%. This contributed to the annual value of $2.0 million for FY2020, which is 246.55% down from last year.
  • Arbutus Biopharma's Depreciation Expense amounted to $447000.0 in Q3 2021, which was down 877.55% from $436000.0 recorded in Q2 2021.
  • Arbutus Biopharma's 5-year Depreciation Expense high stood at $620000.0 for Q4 2017, and its period low was $334000.0 during Q1 2017.
  • Its 5-year average for Depreciation Expense is $502105.3, with a median of $501000.0 in 2020.
  • In the last 5 years, Arbutus Biopharma's Depreciation Expense surged by 10378.01% in 2017 and then tumbled by 1870.97% in 2018.
  • Quarter analysis of 5 years shows Arbutus Biopharma's Depreciation Expense stood at $620000.0 in 2017, then decreased by 18.71% to $504000.0 in 2018, then rose by 0.6% to $507000.0 in 2019, then fell by 3.94% to $487000.0 in 2020, then fell by 8.21% to $447000.0 in 2021.
  • Its Depreciation Expense was $447000.0 in Q3 2021, compared to $436000.0 in Q2 2021 and $443000.0 in Q1 2021.